share_log

HC Wainwright & Co. Reiterates Buy on Abeona Therapeutics, Maintains $15 Price Target

Benzinga ·  Mar 24 10:59

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $15 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 243

Recommended

Write a comment